NCT07426484 2026-02-23Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic MalignancyDana-Farber Cancer InstitutePhase 4 Not yet recruiting80 enrolled
NCT01203722 2026-02-19Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic MalignanciesSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1/2 Completed87 enrolled 24 charts